QLINEAQ-linea AB (publ)
18.20SEK0.00%Mkt Cap: 32.99M $P/E:

Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom, the United States, France, the Middle East, Belgium, Italy, and Finland…

Key Statistics

Company
Market Cap32.99M $
Enterprise Value16.24M $
Revenue (TTM)1.38M $
Gross Profit-161.94K $
Net Income (TTM)-17.46M $
Revenue/Share0.2075 USD
Last Price18.20 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees70
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0011527845
Valuation
P/E (Trailing)
P/E (Forward)-60.50
PEG
EV/EBITDA-1.23
EV/Revenue11.75
P/S23.81
P/B1.25
EPS (TTM)-5.99
EPS (Forward)-0.30
52W Range
14.559% of range53.60
52W High53.60 SEK
52W Low14.55 SEK
Profitability
Gross Margin-15.26%
Oper. Margin-820.16%
EBITDA Margin0.00%
Profit Margin-1644.31%
ROE-53.99%
ROA-49.36%
Growth
Revenue Growth209.30%
Earnings Growth
Cash Flow & Leverage
Operating CF-15.51M $
CapEx (TTM)723.23K $
FCF Margin-821.24%
FCF Yield-34.40%
Net Debt-16.75M $
Net Debt/EBITDA1.27
Balance Sheet
Debt/Equity0.02
Current Ratio117.99
Quick Ratio85.48
Book Value/Sh14.50 SEK
Cash/Share9.857 SEK
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 SEK
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:1000
Split DateJul 14, 2025
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.18.95M
Float11.64M
Insiders12.92%
Institutions27.38%
Technical
SMA 5017.51 (+4.0%)
SMA 20021.48 (-15.3%)
Beta0.58
S&P 52W Chg18.16%
Avg Vol (30d)8.21K
Avg Vol (10d)15.71K
Technical Indicators
RSI (14)53.3
MACD0.2084
MACD Signal0.2117
MACD Hist.-0.0033
BB Upper19.62 SEK
BB Middle17.82 SEK
BB Lower16.02 SEK
BB Width20.21%
ATR (14)0.9892 SEK
Vol Ratio (20d)0.08x